Previous Article | Next Article ![]()
Infection and Immunity, July 2007, p. 3498-3505, Vol. 75, No. 7
0019-9567/07/$08.00+0 doi:10.1128/IAI.00232-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan 48109-0642,1 Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, Michigan 482012
Received 12 February 2007/ Returned for modification 3 March 2007/ Accepted 23 April 2007
Candida albicans produces lipid metabolites that are functionally similar to host prostaglandins. These studies, using mass spectrometry, demonstrate that C. albicans produces authentic prostaglandin E2 (PGE2) from arachidonic acid. Maximal PGE2 production was achieved at 37°C in stationary-phase culture supernatants and in cell-free lysates generated from stationary-phase cells. Interestingly, PGE2 production is inhibited by both nonspecific cyclooxygenase and lipoxygenase inhibitors but not by inhibitors specific for the cyclooxygenase 2 isoenzyme. The C. albicans genome does not possess a cyclooxygenase homolog; however, several genes that may play a role in prostaglandin production from C. albicans were investigated. It was found that a C. albicans fatty acid desaturase homolog (Ole2) and a multicopper oxidase homolog (Fet3) play roles in prostaglandin production, with ole2/ole2 and fet3/fet3 mutant strains exhibiting reduced PGE2 levels compared with parent strains. This work demonstrates that the synthesis of PGE2 in C. albicans proceeds via novel pathways.
Published ahead of print on 30 April 2007.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»